发布求助
文献互助 智能选刊 最新文献

Clinical and Molecular Hepatology最新文献

筛选
英文 中文
Reply to "Development of risk scores for prognosis prediction among patients with early-stage hepatocellular carcinoma". 对 "早期肝细胞癌患者预后预测风险评分的开发 "的答复
IF 14 1区 医学
Clinical and Molecular Hepatology Pub Date : 2024-11-06 DOI: 10.3350/cmh.2024.0946
Chun-Ting Ho, Elise Chia-Hui Tan, Chien-Wei Su
{"title":"Reply to \"Development of risk scores for prognosis prediction among patients with early-stage hepatocellular carcinoma\".","authors":"Chun-Ting Ho, Elise Chia-Hui Tan, Chien-Wei Su","doi":"10.3350/cmh.2024.0946","DOIUrl":"https://doi.org/10.3350/cmh.2024.0946","url":null,"abstract":"","PeriodicalId":10275,"journal":{"name":"Clinical and Molecular Hepatology","volume":" ","pages":""},"PeriodicalIF":14.0,"publicationDate":"2024-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142582167","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reply to correspondence on "Understanding the impact on digestive disease in the post-COVID-19 condition". 对关于 "了解后 COVID-19 条件对消化系统疾病的影响 "的信函的答复。
IF 14 1区 医学
Clinical and Molecular Hepatology Pub Date : 2024-11-06 DOI: 10.3350/cmh.2024.0966
Yang-Hyun Baek
{"title":"Reply to correspondence on \"Understanding the impact on digestive disease in the post-COVID-19 condition\".","authors":"Yang-Hyun Baek","doi":"10.3350/cmh.2024.0966","DOIUrl":"https://doi.org/10.3350/cmh.2024.0966","url":null,"abstract":"","PeriodicalId":10275,"journal":{"name":"Clinical and Molecular Hepatology","volume":" ","pages":""},"PeriodicalIF":14.0,"publicationDate":"2024-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142582173","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A novel clinical trial for primary sclerosing cholangitis from Asia: all regional endeavors should improve global management of PSC. 来自亚洲的原发性硬化性胆管炎新型临床试验：所有地区的努力都应改善全球对原发性硬化性胆管炎的管理。
IF 14 1区 医学
Clinical and Molecular Hepatology Pub Date : 2024-11-06 DOI: 10.3350/cmh.2024.0945
Atsumasa Komori
{"title":"A novel clinical trial for primary sclerosing cholangitis from Asia: all regional endeavors should improve global management of PSC.","authors":"Atsumasa Komori","doi":"10.3350/cmh.2024.0945","DOIUrl":"https://doi.org/10.3350/cmh.2024.0945","url":null,"abstract":"","PeriodicalId":10275,"journal":{"name":"Clinical and Molecular Hepatology","volume":" ","pages":""},"PeriodicalIF":14.0,"publicationDate":"2024-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142582151","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correspondence on Letter regarding "Transarterial radioembolization versus tyrosine kinase inhibitor in hepatocellular carcinoma with portal vein thrombosis". 关于 "肝细胞癌伴有门静脉血栓形成时经动脉放射栓塞术与酪氨酸激酶抑制剂的对比 "信件的通信。
IF 14 1区 医学
Clinical and Molecular Hepatology Pub Date : 2024-11-06 DOI: 10.3350/cmh.2024.0943
Moon Haeng Hur, Yoon Jun Kim
{"title":"Correspondence on Letter regarding \"Transarterial radioembolization versus tyrosine kinase inhibitor in hepatocellular carcinoma with portal vein thrombosis\".","authors":"Moon Haeng Hur, Yoon Jun Kim","doi":"10.3350/cmh.2024.0943","DOIUrl":"https://doi.org/10.3350/cmh.2024.0943","url":null,"abstract":"","PeriodicalId":10275,"journal":{"name":"Clinical and Molecular Hepatology","volume":" ","pages":""},"PeriodicalIF":14.0,"publicationDate":"2024-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142582157","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Correspondence on Letter Regarding "Contemporary Awareness of Viral Hepatitis between 2012 and 2022 among Korean Adults". 关于 "2012 年至 2022 年韩国成年人对病毒性肝炎的当代认识 "信函的通信。
IF 14 1区 医学
Clinical and Molecular Hepatology Pub Date : 2024-11-06 DOI: 10.3350/cmh.2024.0944
Chang Hun Lee, In Hee Kim, Sook-Hyang Jeong
{"title":"Correspondence on Letter Regarding \"Contemporary Awareness of Viral Hepatitis between 2012 and 2022 among Korean Adults\".","authors":"Chang Hun Lee, In Hee Kim, Sook-Hyang Jeong","doi":"10.3350/cmh.2024.0944","DOIUrl":"https://doi.org/10.3350/cmh.2024.0944","url":null,"abstract":"","PeriodicalId":10275,"journal":{"name":"Clinical and Molecular Hepatology","volume":" ","pages":""},"PeriodicalIF":14.0,"publicationDate":"2024-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142582153","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Stabilizing Hepatic Fatty Acid Oxidation: USP29 Secures Acyl-CoA Synthesis through ACSL5. 稳定肝脏脂肪酸氧化：USP29 通过 ACSL5 确保酰基-CoA 的合成
IF 14 1区 医学
Clinical and Molecular Hepatology Pub Date : 2024-11-06 DOI: 10.3350/cmh.2024.0971
Myeung Gi Choi, Na Young Lee, Ja Hyun Koo
{"title":"Stabilizing Hepatic Fatty Acid Oxidation: USP29 Secures Acyl-CoA Synthesis through ACSL5.","authors":"Myeung Gi Choi, Na Young Lee, Ja Hyun Koo","doi":"10.3350/cmh.2024.0971","DOIUrl":"https://doi.org/10.3350/cmh.2024.0971","url":null,"abstract":"","PeriodicalId":10275,"journal":{"name":"Clinical and Molecular Hepatology","volume":" ","pages":""},"PeriodicalIF":14.0,"publicationDate":"2024-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142582184","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Insights on Risk Score Development: Considerations for Early-Stage Hepatocellular Carcinoma Models. 风险评分开发的启示：早期肝细胞癌模型的注意事项
IF 14 1区 医学
Clinical and Molecular Hepatology Pub Date : 2024-11-06 DOI: 10.3350/cmh.2024.0958
Zhanna Zhang, Gongqiang Wu
{"title":"Insights on Risk Score Development: Considerations for Early-Stage Hepatocellular Carcinoma Models.","authors":"Zhanna Zhang, Gongqiang Wu","doi":"10.3350/cmh.2024.0958","DOIUrl":"https://doi.org/10.3350/cmh.2024.0958","url":null,"abstract":"","PeriodicalId":10275,"journal":{"name":"Clinical and Molecular Hepatology","volume":" ","pages":""},"PeriodicalIF":14.0,"publicationDate":"2024-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142582163","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Response to the letter. 回信。
IF 14 1区 医学
Clinical and Molecular Hepatology Pub Date : 2024-11-04 DOI: 10.3350/cmh.2024.0937
Hee Yeon Kim, Miyoung Choi, Dae Won Jun
{"title":"Response to the letter.","authors":"Hee Yeon Kim, Miyoung Choi, Dae Won Jun","doi":"10.3350/cmh.2024.0937","DOIUrl":"https://doi.org/10.3350/cmh.2024.0937","url":null,"abstract":"","PeriodicalId":10275,"journal":{"name":"Clinical and Molecular Hepatology","volume":" ","pages":""},"PeriodicalIF":14.0,"publicationDate":"2024-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142567588","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Challenges and Innovations in PSC Clinical Trials: Evaluating HK-660S and the Path Forward. PSC 临床试验的挑战与创新：评估 HK-660S 和前进之路。
IF 14 1区 医学
Clinical and Molecular Hepatology Pub Date : 2024-11-04 DOI: 10.3350/cmh.2024.0942
Nilanga Nishad
{"title":"Challenges and Innovations in PSC Clinical Trials: Evaluating HK-660S and the Path Forward.","authors":"Nilanga Nishad","doi":"10.3350/cmh.2024.0942","DOIUrl":"https://doi.org/10.3350/cmh.2024.0942","url":null,"abstract":"","PeriodicalId":10275,"journal":{"name":"Clinical and Molecular Hepatology","volume":" ","pages":""},"PeriodicalIF":14.0,"publicationDate":"2024-11-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142567586","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
ALCOHOL-ASSOCIATED LIVER DISEASE: NATURAL HISTORY, MANAGEMENT AND NOVEL TARGETED THERAPIES. 酒精相关肝病：自然史、管理和新型靶向疗法。
IF 14 1区 医学
Clinical and Molecular Hepatology Pub Date : 2024-10-31 DOI: 10.3350/cmh.2024.0709
Edilmar Alvarado-Tapias, Elisa Pose, Jordi Gratacós, Ana Clemente-Sánchez, Hugo Hugo López-Pelayo, Ramón Bataller
{"title":"ALCOHOL-ASSOCIATED LIVER DISEASE: NATURAL HISTORY, MANAGEMENT AND NOVEL TARGETED THERAPIES.","authors":"Edilmar Alvarado-Tapias, Elisa Pose, Jordi Gratacós, Ana Clemente-Sánchez, Hugo Hugo López-Pelayo, Ramón Bataller","doi":"10.3350/cmh.2024.0709","DOIUrl":"https://doi.org/10.3350/cmh.2024.0709","url":null,"abstract":"<p><p>Alcohol consumption is a leading cause of preventable morbidity and mortality worldwide and the primary cause of advanced liver disease. Alcohol use disorder (AUD) is a chronic, frequently relapsing condition characterized by persistent alcohol consumption despite its negative consequences. Alcohol-associated liver disease (ALD) encompasses a series of stages, from fatty liver (steatosis) to inflammation (steatohepatitis), fibrosis, and, ultimately, liver cirrhosis and its complications. The development of ALD is complex, involving both genetic and environmental factors, yet the exact mechanisms at play remain unclear. Alcohol-associated hepatitis (AH), a severe form of ALD, presents with sudden jaundice and liver failure. Currently, there are no approved targeted therapies able to interfere in the pathogenesis of ALD to stop the progression of the disease, making alcohol abstinence the most effective way to improve prognosis across all stages of ALD. For patients with advanced ALD who do not respond to medical therapy, liver transplantation is the only option that can improve prognosis. Recently, AH has become an early indication for liver transplantation in non-responders to medical treatment, showing promising results in carefully selected patients. This review provides an update on the epidemiology, natural history, pathogenesis, and current treatments for ALD. A deeper insight into novel targeted therapies investigated for AH focusing on new pathophysiologically-based agents is also discussed, including anti-inflammatory and antioxidative stress drugs, gut-liver axis modulators, and hepatocyte regenerative molecules.</p>","PeriodicalId":10275,"journal":{"name":"Clinical and Molecular Hepatology","volume":" ","pages":""},"PeriodicalIF":14.0,"publicationDate":"2024-10-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142557300","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
首页 上一页 下一页 尾页
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整，为了账户安全，请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们：info@booksci.cn Book学术提供免费学术资源搜索服务，方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号：481959085
Book学术官方微信